CASSIAN YEE to Immunotherapy, Adoptive
This is a "connection" page, showing publications CASSIAN YEE has written about Immunotherapy, Adoptive.
Connection Strength
2.886
-
Adoptive T cell therapy: points to consider. Curr Opin Immunol. 2018 04; 51:197-203.
Score: 0.302
-
Personalized Therapy: Tumor Antigen Discovery for Adoptive Cellular Therapy. Cancer J. 2017 Mar/Apr; 23(2):144-148.
Score: 0.279
-
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression. J Clin Oncol. 2016 11 01; 34(31):3787-3795.
Score: 0.273
-
Endogenous T-Cell Therapy: Clinical Experience. Cancer J. 2015 Nov-Dec; 21(6):492-500.
Score: 0.254
-
Adoptive therapy using antigen-specific T-cell clones. Cancer J. 2010 Jul-Aug; 16(4):367-73.
Score: 0.176
-
Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma. PLoS One. 2009; 4(3):e4749.
Score: 0.160
-
Adoptive T-cell therapy of cancer. Hematol Oncol Clin North Am. 2006 Jun; 20(3):711-33.
Score: 0.132
-
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy. J Immunother Cancer. 2023 04; 11(4).
Score: 0.106
-
Adoptive T cell therapy--immune monitoring and MHC multimers. Clin Immunol. 2003 Jan; 106(1):5-9.
Score: 0.105
-
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci U S A. 2002 Dec 10; 99(25):16168-73.
Score: 0.103
-
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy. J Immunother Cancer. 2021 05; 9(5).
Score: 0.093
-
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. J Immunother Cancer. 2021 05; 9(5).
Score: 0.093
-
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med. 2000 Dec 04; 192(11):1637-44.
Score: 0.090
-
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy. J Immunother Cancer. 2020 04; 8(1).
Score: 0.086
-
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells. Cancer Immunol Res. 2020 06; 8(6):794-805.
Score: 0.086
-
An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:e70-e78.
Score: 0.081
-
Prospects for adoptive T cell therapy. Curr Opin Immunol. 1997 Oct; 9(5):702-8.
Score: 0.073
-
The use of endogenous T cells for adoptive transfer. Immunol Rev. 2014 Jan; 257(1):250-63.
Score: 0.056
-
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I. Cancer Immunol Res. 2014 Jan; 2(1):27-36.
Score: 0.056
-
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer. J Immunother. 2012 Feb-Mar; 35(2):131-41.
Score: 0.049
-
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy. Clin Cancer Res. 2011 Apr 01; 17(7):1664-73.
Score: 0.046
-
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res. 2005 Feb 15; 65(4):1570-6.
Score: 0.030
-
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling. CPT Pharmacometrics Syst Pharmacol. 2023 11; 12(11):1577-1590.
Score: 0.027
-
Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell. 2003 May; 3(5):431-7.
Score: 0.027
-
Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends. J Clin Invest. 2002 Nov; 110(10):1415-7.
Score: 0.026
-
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. Clin Cancer Res. 2022 05 02; 28(9):1911-1924.
Score: 0.025
-
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nat Commun. 2020 10 21; 11(1):5332.
Score: 0.022
-
Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapy. Ciba Found Symp. 1994; 187:212-23; discussion 224-8.
Score: 0.014
-
Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy. Cancer Res. 2013 Apr 15; 73(8):2598-607.
Score: 0.013